Results 91 to 100 of about 6,881 (206)

The Association Between Number of Chronic Conditions and Benzodiazepine Prescribing in Region Stockholm, Sweden: A Total Population‐Based Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims The aim of this study was to examine the association between an increasing number of chronic conditions and prescribing of benzodiazepines. Methods Conditional logistic regression was used to study the association between the number of chronic conditions accumulated during a 4‐year period and risk of having ≥ 2 collected ...
Caroline Kappelin   +3 more
wiley   +1 more source

Deprescribing within English care homes: guidance and recommendations from the STOPPING project

open access: yesHealth Literacy and Communication Open
Background Care home residents often experience polypharmacy. Deprescribing, or the reduction or stopping of prescription medicines that may no longer be providing benefit, is generally safe but it is unknown how to make it work well in care homes.Aim ...
Krystal Warmoth, Alex Aylward, Jo Day
doaj   +1 more source

Use of STOPPFrail Medications Following Receipt of the Danish Terminal Grant: A Nationwide Descriptive Study

open access: yes
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 3, September 2026.
Daniel Pilsgaard Henriksen   +2 more
wiley   +1 more source

Type 2 Diabetes Mellitus: Molecular Pathogenesis and Therapeutic Interventions

open access: yesMedComm, Volume 7, Issue 8, August 2026.
This graphical summary illustrates the multiorgan therapeutic landscape for Type 2 diabetes mellitus (T2D), integrating molecular pathogenesis with modern treatment strategies. It depicts how current interventions, including SGLT2 inhibitors, GLP‐1 receptor agonists, and insulin secretagogues, target key organs—kidney, pancreas, gastrointestinal tract,
Shinuan Fei   +9 more
wiley   +1 more source

“I think deprescribing is very needed in our society:” Healthcare Professional Students Perceptions of Deprescribing Education

open access: yesINNOVATIONS in Pharmacy
Introduction: Deprescribing is a complex and pivotal process in the healthcare system that requires the involvement of different healthcare professionals as well as patients and family members. Given the multifaceted healthcare professionals involved in
Alina Cernasev   +6 more
doaj  

Awareness, perspectives and practices of antibiotics deprescribing among physicians in Jordan: a cross-sectional study

open access: yesJournal of Pharmaceutical Policy and Practice
Background: Antibiotics have significantly reduced mortality and improved outcomes across various medical fields; however, the rise of antibiotic resistance poses a major challenge, causing millions of deaths annually.
Rana Abu-Farha   +6 more
doaj   +1 more source

Distribution of Gastrointestinal and Dietary Risk Factors Among U.S. Adults Classified as Having Iron Deficiency Anemia Across Diagnostic Thresholds

open access: yes
American Journal of Hematology, Volume 101, Issue 8, Page 2095-2099, August 2026.
Omar Al Ta’ani   +6 more
wiley   +1 more source

A Paradoxical Reaction to Lorazepam Prescribed for a Young Person With New Psychotic Symptoms Related to Insomnia: A Case Report

open access: yesProgress in Neurology and Psychiatry, Volume 30, Issue 3, August 2026.
ABSTRACT Paradoxical reactions are uncommon consequences of benzodiazepine treatment. Despite the frequency of lorazepam use in acute psychiatric care, we are not aware of previous reports of paradoxical reactions to lorazepam in children and young people.
Ailsa McKay   +2 more
wiley   +1 more source

Facilitators and barriers to the deprescribing of benzodiazepines and Z-drug hypnotics in patients under 65 on adult mental health wards

open access: yesScientific Reports
There is a place for the use of benzodiazepines/z-hypnotics on adult mental health wards, but they are often continued beyond a length of time where they are beneficial. This can result in dependence and withdrawal effects if stopped.
Sonia Filmer, Ian Maidment
doaj   +1 more source

Promoting Sustainable Prescribing—A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
ABSTRACT During the past two decades, it has become evident that pharmaceuticals is an emerging environmental problem. In this study, we present the experiences from two Swedish Drug & Therapeutics Committees (DTCs) on how they integrate environmental considerations into their formularies and continuous professional education activities.
Björn Ericsson   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy